We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$161M
AUM Growth
Cap. Flow
+$155M
Cap. Flow %
96.34%
Top 10 Hldgs %
42.42%
Holding
67
New
67
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 32.26%
2 Technology 13.57%
3 Industrials 13.18%
4 Financials 8.4%
5 Consumer Discretionary 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZSPH
26
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$2.52M 1.57%
+60,000
New +$2.74M
GTN icon
27
Gray Television
GTN
$552M
$2.41M 1.5%
+174,200
New +$1.98M
SUM
28
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$2.32M 1.44%
+111,008
New +$2.26M
FSB
29
DELISTED
Franklin Financial Network, Inc.
FSB
$2.1M 1.31%
+100,000
New +$2.1M
NVAX icon
30
Novavax
NVAX
$1.31B
$2.07M 1.29%
+12,500
New +$2.03M
MPG
31
DELISTED
Metaldyne Performance Group Inc.
MPG
$1.74M 1.08%
+96,481
New +$1.79M
DPLO
32
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.73M 1.08%
+50,000
New +$1.36M
GSBD icon
33
Goldman Sachs BDC
GSBD
$1.1B
$1.67M 1.04%
+80,850
New +$1.68M
HUBS icon
34
HubSpot
HUBS
$10.5B
$1.6M 0.99%
+40,000
New +$1.49M
HTLD icon
35
Heartland Express
HTLD
$956M
$1.56M 0.97%
+65,600
New +$1.66M
ITCI
36
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.53M 0.95%
+63,978
New +$1.43M
RCPT
37
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.51M 0.94%
+9,145
New +$1.16M
ICPT
38
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.41M 0.88%
+5,000
New +$1.08M
INSM icon
39
Insmed
INSM
$28.6B
$1.25M 0.78%
+60,000
New +$1.06M
TVTX icon
40
Travere Therapeutics
TVTX
$5.78B
$1.2M 0.75%
+50,000
New +$762K
SCMP
41
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$1.17M 0.73%
+75,000
New +$1.16M
DRII
42
DELISTED
DIAMOND RESORTS INTL, INC
DRII
$1.16M 0.72%
+34,800
New +$1.09M
FRC
43
DELISTED
First Republic Bank
FRC
$1.14M 0.71%
+20,000
New +$1.09M
CALD
44
DELISTED
Callidus Software, Inc.
CALD
$1.14M 0.71%
+90,000
New +$1.31M
EPZM
45
DELISTED
Epizyme, Inc
EPZM
$1.11M 0.69%
+59,100
New +$1.22M
NPBC
46
DELISTED
NATL PENN BANCSHARES INC
NPBC
$1.08M 0.67%
+100,000
New +$1.05M
CNCE
47
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.02M 0.64%
+67,500
New +$942K
TARA icon
48
Protara Therapeutics
TARA
$232M
$964K 0.6%
+2,073
New +$910K
ABUS icon
49
Arbutus Biopharma
ABUS
$915M
$960K 0.6%
+55,000
New +$1.13M
TNDM icon
50
Tandem Diabetes Care
TNDM
$1.56B
$858K 0.53%
+6,800
New +$884K

Similar funds

Monashee Investment Management's Q1 2015 Portfolio in Review

Q1 2015 is the first quarter with a 13F filing on record for Monashee Investment Management, which disclosed 67 positions worth $161M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Viatris: 175,000 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, followed by Technology and Industrials.

  • Monashee Investment Management's largest Q1 2015 buy was Viatris: 175,000 shares worth $10.4M.
  • Monashee Investment Management's ten largest holdings make up 42% of its $161M portfolio in Q1 2015.
  • Monashee Investment Management disclosed 67 positions in Q1 2015, its first 13F filing on record.

Based on Monashee Investment Management's 13F filing for Q1 2015, filed 20 Apr 2015.